Scientists discover new target for treating aggressive brain cancer

A study co-led by UCLA scientists has found targeting a protein called endocan and its related signaling pathway could be a promising new approach for treating glioblastoma, an aggressive and lethal type of brain cancer.

Generic group sues Minnesota over a drug pricing transparency law it calls an ‘unconstitutional overreach’

The trade group for generic drug companies has filed a lawsuit alleging a Minnesota law that is designed to provide transparency into prescription drug pricing

July 6, 2023

Sanofi bows to FTC demands and ends Maze licensing deal – Pharmaceutical Technology

Share this article Maze Therapeutics believes that the FTC complaint on a deal with Sanofi centered on its Pompe disease programme lacks any legal basis.

December 14, 2023

Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic | Psychedelic Invest

SARASOTA, FL, Aug. 14, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug

August 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.